2020 Targeting ALK - From Discovery to Frontline Treatment
6 Visualizações
• 07/30/23
0
0
Embutir
administrator
Assinantes
In this 'keynote', Dr. Yael Mosse presents on the discovery of ALK aberrations in neuroblastoma, their significance at diagnosis and at relapse, drug development strategies and plans to incorporate ALK inhibitors into frontline therapy with potential joint COG and SIOPEN studies, and germline ALK mutation.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários